ASX - By Stock
|
BGT |
Re:
IPO - Bio-Gene Technology Ltd
|
|
RAllen50
|
111 |
57K |
1 |
30/11/17 |
30/11/17 |
ASX - By Stock
|
111
|
57K
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Agreement with Jinzi for Six C-MABR Plants
|
|
RAllen50
|
77 |
31K |
18 |
30/11/17 |
30/11/17 |
ASX - By Stock
|
77
|
31K
|
18
|
|
ASX - By Stock
|
JAV |
Re:
Ann: New Copper Gossan Discovery & Gravity Survey Underway
|
|
RAllen50
|
59 |
19K |
3 |
29/11/17 |
29/11/17 |
ASX - By Stock
|
59
|
19K
|
3
|
|
ASX - By Stock
|
JAV |
Re:
Ann: New Copper Gossan Discovery & Gravity Survey Underway
|
|
RAllen50
|
59 |
19K |
0 |
28/11/17 |
28/11/17 |
ASX - By Stock
|
59
|
19K
|
0
|
|
ASX - By Stock
|
JAV |
Re:
Ann: New Copper Gossan Discovery & Gravity Survey Underway
|
|
RAllen50
|
59 |
19K |
0 |
28/11/17 |
28/11/17 |
ASX - By Stock
|
59
|
19K
|
0
|
|
IPOs
|
|
Re:
Tymlez blockchain pre IPO
|
|
RAllen50
|
478 |
271K |
8 |
28/11/17 |
28/11/17 |
IPOs
|
478
|
271K
|
8
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Norwood partners with Visa
|
|
RAllen50
|
361 |
102K |
5 |
26/11/17 |
26/11/17 |
ASX - By Stock
|
361
|
102K
|
5
|
|
ASX - By Stock
|
BGT |
Re:
IPO - Bio-Gene Technology Ltd
|
|
RAllen50
|
111 |
57K |
0 |
25/11/17 |
25/11/17 |
ASX - By Stock
|
111
|
57K
|
0
|
|
ASX - By Stock
|
SPX |
Re:
Ann: Placement of $888,888 and Exploration to commence in Pilbara
|
|
RAllen50
|
96 |
48K |
0 |
24/11/17 |
24/11/17 |
ASX - By Stock
|
96
|
48K
|
0
|
|
ASX - By Stock
|
BGT |
Re:
IPO - Bio-Gene Technology Ltd
|
|
RAllen50
|
111 |
57K |
3 |
24/11/17 |
24/11/17 |
ASX - By Stock
|
111
|
57K
|
3
|
|
ASX - By Stock
|
SPX |
Re:
Ann: Placement of $888,888 and Exploration to commence in Pilbara
|
|
RAllen50
|
96 |
48K |
2 |
24/11/17 |
24/11/17 |
ASX - By Stock
|
96
|
48K
|
2
|
|
ASX - By Stock
|
BGT |
Re:
IPO - Bio-Gene Technology Ltd
|
|
RAllen50
|
111 |
57K |
4 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
111
|
57K
|
4
|
|
ASX - By Stock
|
BGT |
Re:
IPO - Bio-Gene Technology Ltd
|
|
RAllen50
|
111 |
57K |
1 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
111
|
57K
|
1
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera gains approval to disclose anchor customer Abiomed
|
|
RAllen50
|
38 |
16K |
3 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
38
|
16K
|
3
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Norwood partners with Visa
|
|
RAllen50
|
361 |
102K |
6 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
361
|
102K
|
6
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera gains approval to disclose anchor customer Abiomed
|
|
RAllen50
|
38 |
16K |
1 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
38
|
16K
|
1
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Norwood partners with Visa
|
|
RAllen50
|
361 |
102K |
3 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
361
|
102K
|
3
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Capital Raising
|
|
RAllen50
|
173 |
46K |
9 |
18/11/17 |
18/11/17 |
ASX - By Stock
|
173
|
46K
|
9
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera gains approval to disclose anchor customer Abiomed
|
|
RAllen50
|
38 |
16K |
6 |
18/11/17 |
18/11/17 |
ASX - By Stock
|
38
|
16K
|
6
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera gains approval to disclose anchor customer Abiomed
|
|
RAllen50
|
38 |
16K |
2 |
17/11/17 |
17/11/17 |
ASX - By Stock
|
38
|
16K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
IPO - Rhythm Biosciences Limited
|
|
RAllen50
|
151 |
85K |
6 |
17/11/17 |
17/11/17 |
ASX - By Stock
|
151
|
85K
|
6
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera gains approval to disclose anchor customer Abiomed
|
|
RAllen50
|
38 |
16K |
2 |
17/11/17 |
17/11/17 |
ASX - By Stock
|
38
|
16K
|
2
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Capital Raising
|
|
RAllen50
|
173 |
46K |
2 |
16/11/17 |
16/11/17 |
ASX - By Stock
|
173
|
46K
|
2
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Capital Raising
|
|
RAllen50
|
173 |
46K |
1 |
16/11/17 |
16/11/17 |
ASX - By Stock
|
173
|
46K
|
1
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Capital Raising
|
|
RAllen50
|
173 |
46K |
2 |
16/11/17 |
16/11/17 |
ASX - By Stock
|
173
|
46K
|
2
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Capital Raising
|
|
RAllen50
|
173 |
46K |
6 |
16/11/17 |
16/11/17 |
ASX - By Stock
|
173
|
46K
|
6
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Trading Halt
|
|
RAllen50
|
108 |
36K |
17 |
14/11/17 |
14/11/17 |
ASX - By Stock
|
108
|
36K
|
17
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Trading Halt
|
|
RAllen50
|
108 |
36K |
3 |
14/11/17 |
14/11/17 |
ASX - By Stock
|
108
|
36K
|
3
|
|
ASX - By Stock
|
NOR |
Re:
Worst company ever
|
|
RAllen50
|
11 |
4.4K |
0 |
14/11/17 |
14/11/17 |
ASX - By Stock
|
11
|
4.4K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera Appoints Ralph Schmitt as Chief Executive Officer
|
|
RAllen50
|
21 |
7.4K |
5 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
21
|
7.4K
|
5
|
|
IPOs
|
|
Re:
IPO - Rhythm Bioscience (RHY)
|
|
RAllen50
|
50 |
20K |
5 |
06/11/17 |
06/11/17 |
IPOs
|
50
|
20K
|
5
|
|
Charts
|
FLC |
Re:
Chart
|
|
RAllen50
|
8.0K |
3.5M |
14 |
06/11/17 |
06/11/17 |
Charts
|
8.0K
|
3.5M
|
14
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera Appoints Ralph Schmitt as Chief Executive Officer
|
|
RAllen50
|
21 |
7.4K |
5 |
03/11/17 |
03/11/17 |
ASX - By Stock
|
21
|
7.4K
|
5
|
|
ASX - By Stock
|
NOR |
Re:
Should you buy Norwood?
|
|
RAllen50
|
3 |
1.7K |
3 |
02/11/17 |
02/11/17 |
ASX - By Stock
|
3
|
1.7K
|
3
|
|
IPOs
|
|
Re:
IPO - Rhythm Bioscience (RHY)
|
|
RAllen50
|
50 |
20K |
0 |
02/11/17 |
02/11/17 |
IPOs
|
50
|
20K
|
0
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
RAllen50
|
266 |
75K |
0 |
01/11/17 |
01/11/17 |
ASX - By Stock
|
266
|
75K
|
0
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
RAllen50
|
266 |
75K |
2 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
266
|
75K
|
2
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
RAllen50
|
266 |
75K |
3 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
266
|
75K
|
3
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Launch of World Secure, an Enterprise Cyber-Security Tool
|
|
RAllen50
|
68 |
19K |
0 |
30/10/17 |
30/10/17 |
ASX - By Stock
|
68
|
19K
|
0
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Launch of World Secure, an Enterprise Cyber-Security Tool
|
|
RAllen50
|
68 |
19K |
2 |
30/10/17 |
30/10/17 |
ASX - By Stock
|
68
|
19K
|
2
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Norwood's Corona CRM Available in Oracle Cloud Marketplace
|
|
RAllen50
|
65 |
20K |
7 |
28/10/17 |
28/10/17 |
ASX - By Stock
|
65
|
20K
|
7
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera investor update conference call 16 Oct - amended
|
|
RAllen50
|
26 |
9.4K |
1 |
26/10/17 |
26/10/17 |
ASX - By Stock
|
26
|
9.4K
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Ann: FLC wins fish processing treatment contract in South America
|
|
RAllen50
|
36 |
13K |
6 |
24/10/17 |
24/10/17 |
ASX - By Stock
|
36
|
13K
|
6
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera investor update conference call 16 Oct - amended
|
|
RAllen50
|
26 |
9.4K |
1 |
21/10/17 |
21/10/17 |
ASX - By Stock
|
26
|
9.4K
|
1
|
|
Charts
|
FLC |
Re:
Chart
|
|
RAllen50
|
8.0K |
3.5M |
2 |
21/10/17 |
21/10/17 |
Charts
|
8.0K
|
3.5M
|
2
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera investor update conference call 16 Oct - amended
|
|
RAllen50
|
26 |
9.4K |
1 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
26
|
9.4K
|
1
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera investor update conference call 16 Oct - amended
|
|
RAllen50
|
26 |
9.4K |
0 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
26
|
9.4K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Sensera investor update conference call 16 Oct - amended
|
|
RAllen50
|
26 |
9.4K |
3 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
26
|
9.4K
|
3
|
|
ASX - By Stock
|
BGT |
Re:
IPO - Bio-Gene Technology Ltd
|
|
RAllen50
|
111 |
57K |
3 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
111
|
57K
|
3
|
|
Charts
|
FLC |
Re:
Chart
|
|
RAllen50
|
8.0K |
3.5M |
30 |
19/10/17 |
19/10/17 |
Charts
|
8.0K
|
3.5M
|
30
|
|